Randomized Trial of TAS-102 for Refractory Metastatic Colorectal Cancer
Mayer, Robert J, Van Cutsem, Eric, Falcone, Alfredo, Yoshino, Takayuki, Garcia-Carbonero, Rocio, Mizunuma, Nobuyuki, Yamazaki, Kentaro, Shimada, Yasuhiro, Tabernero, Josep, Komatsu, Yoshito, Sobrero, Alberto, Boucher, Eveline, Peeters, Marc, Tran, Ben, Lenz, Heinz-Josef, Zaniboni, Alberto, Hochster, Howard, Cleary, James M, Prenen, Hans, Benedetti, Fabio, Mizuguchi, Hirokazu, Makris, Lukas, Ito, Masanobu, Ohtsu, Atsushi
Published in The New England journal of medicine (14.05.2015)
Published in The New England journal of medicine (14.05.2015)
Get full text
Journal Article
Human mass balance study of TAS-102 using 14C analyzed by accelerator mass spectrometry
Lee, James J., Seraj, Jabed, Yoshida, Kenichiro, Mizuguchi, Hirokazu, Strychor, Sandra, Fiejdasz, Jillian, Faulkner, Tyeler, Parise, Robert A., Fawcett, Patrick, Pollice, Laura, Mason, Scott, Hague, Jeremy, Croft, Marie, Nugteren, James, Tedder, Charles, Sun, Weijing, Chu, Edward, Beumer, Jan Hendrik
Published in Cancer chemotherapy and pharmacology (19.01.2016)
Published in Cancer chemotherapy and pharmacology (19.01.2016)
Get full text
Journal Article
A Phase 1, Open-Label, Randomized, Crossover Study Evaluating the Bioavailability of TAS-102 (Trifluridine/Tipiracil) Tablets Relative to an Oral Solution Containing Equivalent Amounts of Trifluridine and Tipiracil
Becerra, Carlos R, Yoshida, Kenichiro, Mizuguchi, Hirokazu, Patel, Manish, Von Hoff, Daniel
Published in Journal of clinical pharmacology (01.06.2017)
Published in Journal of clinical pharmacology (01.06.2017)
Get more information
Journal Article
TAS-102 vs placebo (PBO) in patients (pts) ≥65 years (y) with metastatic colorectal cancer (mCRC): An age-based analysis of the RECOURSE trial
Van Cutsem, Eric, Benedetti, Fabio M., Mizuguchi, Hirokazu, Mayer, Robert J., Ohtsu, Atsushi
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Phase 1 study of oral TAS-102 in patients with refractory metastatic colorectal cancer
Bendell, Johanna C., Rosen, Lee S., Mayer, Robert J., Goldman, Jonathan W., Infante, Jeffrey R., Benedetti, Fabio, Lin, Donghu, Mizuguchi, Hirokazu, Zergebel, Christopher, Patel, Manish R.
Published in Cancer chemotherapy and pharmacology (01.11.2015)
Published in Cancer chemotherapy and pharmacology (01.11.2015)
Get full text
Journal Article
Human mass balance study of TAS-102 using (14)C analyzed by accelerator mass spectrometry
Lee, James J, Seraj, Jabed, Yoshida, Kenichiro, Mizuguchi, Hirokazu, Strychor, Sandra, Fiejdasz, Jillian, Faulkner, Tyeler, Parise, Robert A, Fawcett, Patrick, Pollice, Laura, Mason, Scott, Hague, Jeremy, Croft, Marie, Nugteren, James, Tedder, Charles, Sun, Weijing, Chu, Edward, Beumer, Jan Hendrik
Published in Cancer chemotherapy and pharmacology (01.03.2016)
Published in Cancer chemotherapy and pharmacology (01.03.2016)
Get full text
Journal Article
Mass balance study of TAS-102 using 14 C labeling analyzed by accelerator mass spectrometry
Lee, James J., Seraj, Jabed, Yoshida, Kenichiro, Narurkar, Milind, Mizuguchi, Hirokazu, Strychor, Sandra, Fiejdasz, Jillian, Faulkner, Tyeler, Pollice, Laura, Mason, Scott, Sun, Weijing, Chu, Edward, Croft, Marie, Nguteren, James, Tedder, Charles, Beumer, Jan Hendrik
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
TAS-102 versus placebo (PBO) in patients (pts) ≥65 years (y) with metastatic colorectal cancer (mCRC): An age-based analysis of the recourse trial
Van Cutsem, Eric, Benedetti, Fabio M., Mizuguchi, Hirokazu, Mayer, Robert J., Falcone, Alfredo, Garcia-Carbonero, Rocio, Tabernero, Josep, Sobrero, Alberto F., Peeters, Marc, Zaniboni, Alberto, Yoshino, Takayuki, Shimada, Yasuhiro, Yamazaki, Kentaro, Komatsu, Yoshito, Hochster, Howard S., Lenz, Heinz-Josef, Tran, Ben, Ohtsu, Atsushi
Published in Journal of clinical oncology (01.02.2016)
Published in Journal of clinical oncology (01.02.2016)
Get full text
Journal Article
Human mass balance study of TAS-102 using ^sup 14^C analyzed by accelerator mass spectrometry
Lee, James J, Seraj, Jabed, Yoshida, Kenichiro, Mizuguchi, Hirokazu, Strychor, Sandra, Fiejdasz, Jillian, Faulkner, Tyeler, Parise, Robert A, Fawcett, Patrick, Pollice, Laura, Mason, Scott, Hague, Jeremy, Croft, Marie, Nugteren, James, Tedder, Charles, Sun, Weijing, Chu, Edward, Beumer, Jan Hendrik
Published in Cancer chemotherapy and pharmacology (01.03.2016)
Published in Cancer chemotherapy and pharmacology (01.03.2016)
Get full text
Journal Article
Untreated metastatic diffuse gastric adenocarcinoma (DGAC): Randomized phase III study of S-1 and cisplatin vs. 5-FU and cisplatin (the DIGEST trial)
Ajani, Jaffer A., Abramov, Mikhail, Bondar, Volodymyr, Bondarenko, Igor, Shparyk, Yaroslav V., Gorbunova, Vera, Anatoliy, Hontsa, Vinnyk, Yuriy, Alsina, Maria, Lazarev, Sergey, Feliu, Jaime, Elme, Anneli, Esko, Vivian, Rosati, Gerardo, Abdalla, Kathia Cristina, Verma, Udit N., Benedetti, Fabio M., Aoyama, Takekazu, Mizuguchi, Hirokazu, Makris, Lukas
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Erratum to: Phase 1 study of oral TAS-102 in patients with refractory metastatic colorectal cancer
Bendell, Johanna C., Rosen, Lee S., Mayer, Robert J., Goldman, Jonathan W., Infante, Jeffrey R., Benedetti, Fabio, Lin, Donghu, Mizuguchi, Hirokazu, Zergebel, Christopher, Patel, Manish R.
Published in Cancer chemotherapy and pharmacology (01.02.2016)
Published in Cancer chemotherapy and pharmacology (01.02.2016)
Get full text
Journal Article
Prothrombin activation during carbon tetrachloride-induced acute liver injury in mice
Mizuguchi, Hirokazu, Yamazaki, Yasuo, Shikamoto, Yasuo, Shin, Yongchol, Sonoda, Jiro, Morita, Takashi
Published in Thrombosis research (15.05.2002)
Published in Thrombosis research (15.05.2002)
Get full text
Journal Article